These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

457 related articles for article (PubMed ID: 30907676)

  • 1. Self-assembled nanoparticles of reduction-sensitive poly (lactic-co-glycolic acid)-conjugated chondroitin sulfate A for doxorubicin delivery: preparation, characterization and evaluation.
    Wang XF; Ren J; He HQ; Liang L; Xie X; Li ZX; Zhao JG; Yu JM
    Pharm Dev Technol; 2019 Jul; 24(6):794-802. PubMed ID: 30907676
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduction-sensitive micelles self-assembled from amphiphilic chondroitin sulfate A-deoxycholic acid conjugate for triggered release of doxorubicin.
    Liu H; Wu S; Yu J; Fan D; Ren J; Zhang L; Zhao J
    Mater Sci Eng C Mater Biol Appl; 2017 Jun; 75():55-63. PubMed ID: 28415498
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bile acid-conjugated chondroitin sulfate A-based nanoparticles for tumor-targeted anticancer drug delivery.
    Lee JY; Chung SJ; Cho HJ; Kim DD
    Eur J Pharm Biopharm; 2015 Aug; 94():532-41. PubMed ID: 26149228
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced cancer therapy with pH-dependent and aptamer functionalized doxorubicin loaded polymeric (poly D, L-lactic-co-glycolic acid) nanoparticles.
    Saravanakumar K; Hu X; Shanmugam S; Chelliah R; Sekar P; Oh DH; Vijayakumar S; Kathiresan K; Wang MH
    Arch Biochem Biophys; 2019 Aug; 671():143-151. PubMed ID: 31283911
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preparation, characterisation and in vitro and in vivo evaluation of CD44-targeted chondroitin sulphate-conjugated doxorubicin PLGA nanoparticles.
    Liu P; Chen N; Yan L; Gao F; Ji D; Zhang S; Zhang L; Li Y; Xiao Y
    Carbohydr Polym; 2019 Jun; 213():17-26. PubMed ID: 30879657
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preparation and evaluation of reduction-responsive micelles based on disulfide-linked chondroitin sulfate A-tocopherol succinate for controlled antitumour drug release.
    Cai S; Xie X; Yuan Q; Ding J; Meng L; Li J; He M; Li W; Yu J
    J Pharm Pharmacol; 2021 Sep; 73(10):1405-1417. PubMed ID: 34254648
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Self-assembled micelles based on Chondroitin sulfate/poly (d,l-lactideco-glycolide) block copolymers for doxorubicin delivery.
    Zhang H; Xu J; Xing L; Ji J; Yu A; Zhai G
    J Colloid Interface Sci; 2017 Apr; 492():101-111. PubMed ID: 28073063
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Co-delivery nanoparticles of doxorubicin and chloroquine for improving the anti-cancer effect in vitro.
    Sun JH; Ye C; Bai EH; Zhang LL; Huo SJ; Yu HH; Xiang SY; Yu SQ
    Nanotechnology; 2019 Feb; 30(8):085101. PubMed ID: 30523865
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Facile preparation of core cross-linked nanomicelles based on graft copolymers with pH responsivity and reduction sensitivity for doxorubicin delivery.
    Chen T; Xiao Y; Lu W; Liu S; Gan L; Yu J; Huang J
    Colloids Surf B Biointerfaces; 2018 Jan; 161():606-613. PubMed ID: 29156337
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mn
    Xi J; Da L; Yang C; Chen R; Gao L; Fan L; Han J
    Int J Nanomedicine; 2017; 12():3331-3345. PubMed ID: 28479854
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Co-delivery nanoparticles with characteristics of intracellular precision release drugs for overcoming multidrug resistance.
    Zhang D; Kong YY; Sun JH; Huo SJ; Zhou M; Gui YL; Mu X; Chen H; Yu SQ; Xu Q
    Int J Nanomedicine; 2017; 12():2081-2108. PubMed ID: 28356731
    [TBL] [Abstract][Full Text] [Related]  

  • 12. pH-sensitive nanoparticles of poly(L-histidine)-poly(lactide-co-glycolide)-tocopheryl polyethylene glycol succinate for anti-tumor drug delivery.
    Li Z; Qiu L; Chen Q; Hao T; Qiao M; Zhao H; Zhang J; Hu H; Zhao X; Chen D; Mei L
    Acta Biomater; 2015 Jan; 11():137-50. PubMed ID: 25242647
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Formulation and process optimization of doxorubicin-loaded PLGA nanoparticles and its in vitro release].
    Li JL; Zheng CL; Liu JP; Zhu JB
    Yao Xue Xue Bao; 2013 May; 48(5):759-66. PubMed ID: 23888702
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development and optimization of doxorubicin loaded poly(lactic-co-glycolic acid) nanobubbles for drug delivery into HeLa cells.
    Deng L; Li L; Yang H; Li L; Zhao F; Wu C; Liu Y
    J Nanosci Nanotechnol; 2014 Apr; 14(4):2947-54. PubMed ID: 24734715
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preparation and in vitro/in vivo evaluation of doxorubicin-loaded poly[lactic-co-glycol acid] microspheres using electrospray method for sustained drug delivery and potential intratumoral injection.
    Hsu MY; Huang YT; Weng CJ; Chen CM; Su YF; Chu SY; Tseng JH; Wu RC; Liu SJ
    Colloids Surf B Biointerfaces; 2020 Jun; 190():110937. PubMed ID: 32155454
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preparation and characterization novel polymer-coated magnetic nanoparticles as carriers for doxorubicin.
    Li F; Sun J; Zhu H; Wen X; Lin C; Shi D
    Colloids Surf B Biointerfaces; 2011 Nov; 88(1):58-62. PubMed ID: 21764271
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An all-in-one nanoparticle for overcoming drug resistance: doxorubicin and elacridar co-loaded folate receptor targeted PLGA/MSN hybrid nanoparticles.
    Tonbul H; Şahin A; Öztürk SC; Ultav G; Tavukçuoğlu E; Akbaş S; Aktaş Y; Esendağlı G; Çapan Y
    J Drug Target; 2024 Nov; 32(9):1101-1110. PubMed ID: 38946465
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PLGA based particles as "drug reservoir" for antitumor drug delivery: characterization and cytotoxicity studies.
    Chronopoulou L; Domenici F; Giantulli S; Brasili F; D'Errico C; Tsaouli G; Tortorella E; Bordi F; Morrone S; Palocci C; Silvestri I
    Colloids Surf B Biointerfaces; 2019 Aug; 180():495-502. PubMed ID: 31103709
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Doxorubicin-loaded poly (lactic-co-glycolic acid) nanoparticles coated with chitosan/alginate by layer by layer technology for antitumor applications.
    Chai F; Sun L; He X; Li J; Liu Y; Xiong F; Ge L; Webster TJ; Zheng C
    Int J Nanomedicine; 2017; 12():1791-1802. PubMed ID: 28424550
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biodegradable PLGA implants containing doxorubicin-loaded chitosan nanoparticles for treatment of breast tumor-bearing mice.
    Kefayat A; Vaezifar S
    Int J Biol Macromol; 2019 Sep; 136():48-56. PubMed ID: 31195043
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.